⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HIMS News
Hims & Hers Health, Inc.
Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026
globenewswire.com
HIMS
PharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026
globenewswire.com
NVO
HIMS
PharmaZee GLP-1 Review 2026: Evaluating Telehealth Semaglutide Platforms Amid Industry-Wide Compounding Scrutiny
accessnewswire.com
HIMS
Novo Nordisk issues statement on illegal mass compounding and deceptive advertising by Hims & Hers
globenewswire.com
HIMS
Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care
businesswire.com
HIMS
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
ARKK
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
DIS
XOM
JPM
AMD
PYPL
MRNA
AI
MSTR
SNOW
ABNB
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
GDX
BITO
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
businesswire.com
HIMS
Cold Spring Harbor Laboratory Appoints Jack Abraham and Terri Keogh to Board of Trustees
prnewswire.com
HIMS
EBAY
PINS
POST
UBER
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
ARKK
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
DIS
XOM
JPM
AMD
PYPL
MRNA
AI
MSTR
SNOW
ABNB
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
GDX
YQQQ
Semaglutide Market Size to Reach USD 59.75 Billion by 2033, Experiencing High Demand for an Efficient Treatment for Diabetes and Obesity – SNS Insider
globenewswire.com
NVO
HIMS
CAL